Submissions from 2025
Evaluation of Cangrelor Prescribing Trends Across an Acute Care Health-System, Kayla Mitzel, Jonathan Martinez Gines, Jose Valdes Ledesma, Maria A. Ruiz, and Radhan B. Gopalani
MR-Guided Single-Fraction Stereotactic Ablative Body Radiation Therapy for Extracranial Metastases: The Miami Cancer Institute Experience, Michael Chuong, Robert Herrera, Kathryn Mittauer, Carolina Rojas, Muni Rubens, Adeel Kaiser, Noah Kalman, Nema Bassiri, Antonio Ucar, Federico Albrecht, Fernando deZarraga Jr, Paul Kaywin, Santiago Aparo, Sarah Joseph, Alonso Gutierrez, and Rupesh Kotecha
Music Therapy in Outpatient Oncology, Alexa Marsellos and Evelyn Erwin
Random Fourier Features and Ensemble Learning for 30-Day Readmission Risk in Lung Cancer Surgery, Anshul Saxena, Yanjia Zhang, Zhenwei Zhang, Venkataraghavan Ramamoorthy, and Muni Rubens
Multidisciplinary management strategies for recurrent brain metastasis after prior radiotherapy: An overview, Rupesh Kotecha and Alonso La Rosa
Clinical and Genetic Markers of Vascular Toxicity in Glioblastoma Patients: Insights from NRG Oncology RTOG-0825, Minesh Mehta
Complexity and Experience Grading to Guide Patient Selection for Minimally-invasive Pancreatoduodenectomy: An ISGPS Consensus, Horacio Asbun
Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions, Manmeet Ahluwalia
Leptomeningeal metastatic disease: new frontiers and future directions, Manmeet Ahluwalia
A pilot survey into the landscape of neuro-oncology care in the community, Rupesh Kotecha and Yazmin Odia
Blue Ribbon Committee I Review: Findings and Impact, Michael Zinner
Decorin: matrix-based pan-cancer tumor suppressor, Anshul Saxena, Venkataraghavan Ramamoorthy, Yanjia Zhang, Atulya Khosla, and Muni Rubens
Gabapentinoids confer survival benefit in human glioblastoma, Matthew Hall and Yazmin Odia
Management of Panurethral Strictures by Preputial Graft Urethroplasty: Outcomes From a Tertiary Care Centre, Deerush Sakthivel
Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBC, Reshma Mahtani
Perioperative Risks Associated with the Use of External Fixators in Adult and Pediatric Patients with Trauma, Juan Pretell
Trends and outcomes of heart failure hospitalizations during COVID-19 pandemic, Muni Rubens; Venkataraghavan Ramamoorthy; Anshul Saxena; Atulya Khosla; Peter McGranaghan; Yanjia Zhang; Sandra , Chaparro; and Javier , Jimenez
Unraveling the Crimson puzzle: Two case reports/case series of hemorrhagic cystitis after combination chemotherapy with docetaxel, carboplatin, trastuzumab and pertuzumab in breast cancer, Grace Wang, Yolcar Chamorro, and Ana Sandoval-Leon
Submissions from 2024
Financial barriers and inequity in medical education in India: challenges to training a diverse and representative healthcare workforce, Manmeet Ahluwalia
Comparison of Stereotactic Radiosurgery and Hypofractionated Radiosurgery for Vestibular Schwannomas: A Meta-Analysis of Available Literature, Manmeet Ahluwalia
HER2+ early breast cancer treatment and outcomes by risk of recurrence: a retrospective US electronic health records study, Reshma Mahtani
Multicenter retrospective cohort study of the sequential use of antibody drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2 low metastatic breast cancer (MBC): a subgroup analysis of next generation sequencing results., Reshma Mahtani, Mehmet Zerey, Ana Cristina Sandoval Leon, Lauren Carcas, Joseph Panoff, and Manmeet Ahluwalia
Multi-Institutional Quality Improvement on HER2-Positive and HER2-Low Metastatic Breast Cancer, Reshma Mahtani